D-0725-2026 Class II Ongoing
FDA drug recall D-0725-2026 was initiated by Fresenius Kabi USA, LLC on Jul 16, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter: Hair was found in product The recall status is ongoing. Affected quantity: 59,425 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 29, 2026
- Initiation Date
- Jul 16, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 59,425 vials
Product description
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07
Reason for recall
Presence of Particulate Matter: Hair was found in product
Distribution pattern
Nationwide within in the USA
Code information
Lot #: 6134349, 6134620 Exp. Date 11/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0725-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026